Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Intangibles (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Intangibles for 15 consecutive years, with $21.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Intangibles fell 49.79% year-over-year to $21.1 million, compared with a TTM value of $21.1 million through Sep 2025, down 49.79%, and an annual FY2024 reading of $23.5 million, down 47.73% over the prior year.
  • Intangibles was $21.1 million for Q3 2025 at Sanara MedTech, down from $41.0 million in the prior quarter.
  • Across five years, Intangibles topped out at $46.0 million in Q3 2023 and bottomed at $3.8 million in Q2 2021.
  • Average Intangibles over 5 years is $31.7 million, with a median of $31.9 million recorded in 2022.
  • The sharpest move saw Intangibles skyrocketed 580.83% in 2022, then crashed 49.79% in 2025.
  • Year by year, Intangibles stood at $4.7 million in 2021, then soared by 566.46% to $31.5 million in 2022, then surged by 42.58% to $44.9 million in 2023, then plummeted by 47.73% to $23.5 million in 2024, then decreased by 10.14% to $21.1 million in 2025.
  • Business Quant data shows Intangibles for SMTI at $21.1 million in Q3 2025, $41.0 million in Q2 2025, and $42.0 million in Q1 2025.